Prescribe Right
Prescribe Right
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • Contact Us
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • Contact Us
Pipeline News and Updates
Picture

16 Drugs Added to Knowledgebase

5/20/2022

 
We just added 16 new drugs to the knowledgebase:
  • BI 1015550 a phosphodiesterase 4B (PDE4B) inhibitor being developed for the treatment of idiopathic pulmonary fibrosis by Boehringer Ingelheim
  • MCO-010 a gene therapy being developed for the treatment of Stargardt macular degeneration and retinitis pigmentosa by Nanoscope Therapeutics
  • Blarcamesine a sigma-1 receptor agonist being developed for the treatment of Rett Syndrome, Alzheimer’s disease, Parkinson’s disease dementia and Fragile X Syndrome by Anavex Life Sciences
  • Epcoritamab a bispecific antibody being developed for the treatment of relapsed or refractory large B-cell lymphoma by AbbVie and Genmab
  • Zilucoplan a C5 inhibitor being developed for the treatment of generalized myasthenia gravis by UCB
  • Asundexian a Factor XIa inhibitor being developed for the prevention of non-cardioembolic ischemic stroke and myocardial infarction by Bayer
  • EDP-938 a nonfusion replication inhibitor being developed for the treatment of respiratory syncytial virus (RSV) by Enanta Pharmaceuticals
  • Moderna’s investigational respiratory syncytial virus (RSV) vaccine
  • KSI-301 a VEGF Inhibitor being developed for the treatment of neovascular (wet) age-related macular degeneration, macular edema due to retinal vein occlusion and diabetic macular edema by Kodiak Sciences
  • GFB-887 a transient receptor potential canonical-5 (TRPC5) inhibitor being developed for the treatment of focal segmental glomerulosclerosis (FSGS), diabetic nephropathy by Goldfinch Bio
  • CP101 a microbiome transplant being developed for the prevention of recurrence of C. difficile infection by Finch Therapeutics 
  • Ribitol a pentose alcohol being developed for the treatment of limb-girdle muscular dystrophy type 2i (LGMD2i) by BridgeBio Pharma
  • Amcenestrant a selective estrogen receptor degrader (SERD) being developed for the treatment of ER+/HER2- advanced or metastatic breast cancer by Sanofi
  • Latozinemab an anti-sortilin (SORT1) monoclonal antibody f being developed or the treatment of frontotemporal dementia patients (FTD) with a C9orf72 genetic mutation fro by m Alector and GlaxoSmithKline 
  • Imsidolimab an anti-IL-36R monoclonal antibody being developed for the treatment of hidradenitis suppurativa and pustular psoriasis by AnaptysBio
  • Iberdomide a cereblon ligand being developed for the treatment of systemic lupus erythematosus by Bristol Myers Squibb​
The Prescribe Right Pharmaceutical Pipeline Tracker now allows you to track 1,021 pipeline and recently approved drugs supported by 2,551 announced and published study results.

Comments are closed.
    Stay informed, subscribe to the 
    ​
    Prescribe Right Pharmaceutical Pipeline Tracker
    Latest Tweets from Prescribe Right

    Archives

    March 2023
    February 2023
    January 2023
    December 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    August 2015

    RSS Feed

Services

Pharmaceutical Pipeline Tracker​
Consulting

Company

About
Blog
Tweets

Support

Contact
© COPYRIGHT 2015. ALL RIGHTS RESERVED.